SPX -0.95% VIX -2.46%
NEED TO KNOW: 'DON'T FIGHT THE FED' REMAINS A KEY LESSON FOR STOCK MARKET 
STOCKS SET TO SNAP BACK AS MNUCHIN SAYS U.S. WAS 90% OF THE WAY THERE ON CHINA 
ROBERT MUELLER AGREES TO TESTIFY BEFORE HOUSE COMMITTEES ON JULY 17 
MICRON STOCK RISES 4% AS EARNINGS BEAT LOWERED BAR 
NASDAQ DROPS 1.5%, LEADING BENCHMARKS LOWER, AS FED DAMPENS RATE-CUT ENTHUSIASM 
STOCK MARKET HITS INTRADAY LOWS AS FED'S BULLARD DOWNPLAYS 'HUGE ACTION' IN JULY 
CONSUMER CONFIDENCE FALLS TO LOWEST LEVEL IN 21 MONTHS; NEW-HOME SALES FALTER 
STOCKS OPEN STEADY; POWELL'S SPEECH IN FOCUS 
ANNUAL HOME-PRICE GAINS SLOW FOR 13TH STRAIGHT MONTH: CASE-SHILLER 
10-YEAR TREASURY YIELD DIPS BELOW 2% 
Wed, Jun 26 8:07am


Coherus BioSciences Inc [CHRS]
$21.14 0.20 (0.94%)

CHRS Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 1.51 Billion
CHRS Description

Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.


Visit Website

CHRS Earnings

EPS -0.29 P/E Ratio 0.00
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Thu, May 9, 2019 (48 days ago) +31.14%

CHRS Dividend

Yield --
Ex-Date --
Pay Date --
History --

CHRS Charts

$8.38
52 Week Range
$21.77
Jan 3, 2019
Jun 21, 2019



Symbol Price Day % YTD %
CHRS $21.14 -0.94% 131.80%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy